Back to NBIX
DekaBank Deutsche Girozentrale → NBIX
DekaBank Deutsche Girozentrale NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
10
Latest value
$32.1M
Q3 2026
Peak value
$32.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $7.2M |
| Q3 2025 | $9M |
| Q4 2025 | $7.8M |
| Q4 2025 | $9.8M |
| Q1 2026 | $6.9M |
| Q1 2026 | $8.7M |
| Q2 2026 | $6.7M |
| Q2 2026 | $8.5M |
| Q3 2026 | $18.3M |
| Q3 2026 | $32.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32.1M | 230.8K | — | — |
| Q3 2026 | $18.3M | 132.0K | — | — |
| Q2 2026 | $8.5M | 64.7K | — | — |
| Q2 2026 | $6.7M | 51.3K | — | — |
| Q1 2026 | $8.7M | 64.7K | — | — |
| Q1 2026 | $6.9M | 51.3K | — | — |
| Q4 2025 | $9.8M | 64.7K | — | — |
| Q4 2025 | $7.8M | 51.3K | — | — |
| Q3 2025 | $9M | 64.7K | — | — |
| Q3 2025 | $7.2M | 51.3K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M